Posiphen

Phenyl carbamoyl analogues of physostigmine-esrine were developed to provide longer acting and better tolerated Alzheimer's disease treatment. Posiphen (enantiomer of phenserine: ANVS401 (+)-phenserine) is under investigation in clinical trial NCT02925650 (Early Alzheimer's Disease) Posiphen does not inhibit AChE or BChE, but its major and minor metabolites (+)-N1-norPosiphen and (+)-N1,N8-bisnorPosiphen, respectively, possessed modest AChE inhibitory activity.

General

Type : Derivative of physostigmine-eserine, Carbamate, Drug, Indole

Chemical_Nomenclature : [(3aS,8bR)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-phenylcarbamate

Canonical SMILES : CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C

InChI : InChI=1S\/C20H23N3O2\/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14\/h4-10,13,18H,11-12H2,1-3H3,(H,21,24)\/t18-,20+\/m0\/s1

InChIKey : PBHFNBQPZCRWQP-AZUAARDMSA-N

Other name(s) : posiphen  ||  (+)-phenserine  ||  (+)-Posiphen  ||  Phenserine, (+)-  ||  Buntanetap  ||  R-Phenserine  ||  DB15317  ||  CHEMBL4297417  ||  SCHEMBL23874278


MW : 337.4

Formula : C20H23N3O2

CAS_number : 116839-68-0

PubChem : 11249342

UniChem : PBHFNBQPZCRWQP-AZUAARDMSA-N

Target

Families : Posiphen ligand of proteins in family
ACHE

References (8)

Title : In Silico and Ex Vivo Analyses of the Inhibitory Action of the Alzheimer Drug Posiphen and Primary Metabolites with Human Acetyl- and Butyrylcholinesterase Enzymes - Batool_2022_ACS.Pharmacol.Transl.Sci_5_70
Author(s) : Batool S , Furqan T , Hasan Mahmood MS , Tweedie D , Kamal MA , Greig NH
Ref : ACS Pharmacol Transl Sci , 5 :70 , 2022
Abstract :
PubMedSearch : Batool_2022_ACS.Pharmacol.Transl.Sci_5_70
PubMedID: 35178511

Title : Post-treatment with Posiphen Reduces Endoplasmic Reticulum Stress and Neurodegeneration in Stroke Brain - Yu_2020_iScience_23_100866
Author(s) : Yu SJ , Wu KJ , Bae E , Wang YS , Chiang CW , Kuo LW , Harvey BK , Greig NH , Wang Y
Ref : iScience , 23 :100866 , 2020
Abstract :
PubMedSearch : Yu_2020_iScience_23_100866
PubMedID: 32058974

Title : (-)-Phenserine Ameliorates Contusion Volume, Neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice - Hsueh_2019_Cell.Transplant_28_1183
Author(s) : Hsueh SC , Lecca D , Greig NH , Wang JY , Selman W , Hoffer BJ , Miller JP , Chiang YH
Ref : Cell Transplantation , 28 :1183 , 2019
Abstract :
PubMedSearch : Hsueh_2019_Cell.Transplant_28_1183
PubMedID: 31177840

Title : Alzheimer's Disease and Its Potential Alternative Therapeutics - Kisby_2019_J.Alzheimers.Dis.Parkinsonism_9_
Author(s) : Kisby B , Jarrell JT , Agar ME , Cohen DS , Rosin ER , Cahill CM , Rogers JT , Huang X
Ref : J Alzheimers Dis Parkinsonism , 9 : , 2019
Abstract :
PubMedSearch : Kisby_2019_J.Alzheimers.Dis.Parkinsonism_9_
PubMedID: 31588368

Title : Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, alpha -Synuclein Synthesis, Interleukin-1beta Release, and Cholinergic Action - Yu_2013_Antiinflamm.Antiallergy.Agents.Med.Chem_12_117
Author(s) : Yu QS , Reale M , Kamal MA , Holloway HW , Luo W , Sambamurti K , Ray B , Lahiri DK , Rogers JT , Greig NH
Ref : Antiinflamm Antiallergy Agents Med Chem , 12 :117 , 2013
Abstract :
PubMedSearch : Yu_2013_Antiinflamm.Antiallergy.Agents.Med.Chem_12_117
PubMedID: 23360256

Title : The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression - Mikkilineni_2012_Parkinsons.Dis_2012_142372
Author(s) : Mikkilineni S , Cantuti-Castelvetri I , Cahill CM , Balliedier A , Greig NH , Rogers JT
Ref : Parkinsons Dis , 2012 :142372 , 2012
Abstract :
PubMedSearch : Mikkilineni_2012_Parkinsons.Dis_2012_142372
PubMedID: 22693681

Title : The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice - Lahiri_2007_J.Pharmacol.Exp.Ther_320_386
Author(s) : Lahiri DK , Chen D , Maloney B , Holloway HW , Yu QS , Utsuki T , Giordano T , Sambamurti K , Greig NH
Ref : Journal of Pharmacology & Experimental Therapeutics , 320 :386 , 2007
Abstract :
PubMedSearch : Lahiri_2007_J.Pharmacol.Exp.Ther_320_386
PubMedID: 17003227

Title : Phenserine - Klein_2007_Expert.Opin.Investig.Drugs_16_1087
Author(s) : Klein J
Ref : Expert Opin Investig Drugs , 16 :1087 , 2007
Abstract :
PubMedSearch : Klein_2007_Expert.Opin.Investig.Drugs_16_1087
PubMedID: 17594192